Loeb & Loeb LLP is proud to sponsor the American Conference Institute’s (ACI) 17th Annual Paragraph IV Disputes taking place from April 26-27, 2022 where Co-Chair, Life Sciences; Chair, Patent Litigation & Counseling, Mark Waddell will be speaking on the panel "The Ethical Practice of Paragraph IV Litigation" on April 27.
From the event website:
Each year, leading pharmaceutical patent litigators for brand name and generic drug companies along with representatives from key government agencies and the Federal Judiciary gather at ACI’s Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation. As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape as well as the impact of the global pandemic, the time for this conference has never been more relevant.
For more information, including how to register, please visit the event website.